The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Chemical predictive modelling to improve compound quality
Open accessAbstract
The 'quality' of small-molecule drug candidates — encompassing aspects including their potency, selectivity and pharmacokinetic characteristics — is a key factor influencing the chances of success in clinical trials. Cumming and colleagues discuss the application of computational methods, particularly quantitative structure–activity relationships, in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their impact. The 'quality' of small-molecule drug candidates, encompassing aspects including their potency, selectivity and ADMET (absorption, distribution, metabolism, excretion and toxicity) characteristics, is a key factor influencing the chances of success in clinical trials. Importantly, such characteristics are under the control of chemists during the identification and optimization of lead compounds. Here, we discuss the application of computational methods, particularly quantitative structure–activity relationships (QSARs), in guiding the selection of higher-quality drug candidates, as well as cultural factors that may have affected their use and impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
The R Project in Statistical Computing
Ripley, B. D. (2001) · MSOR Connections · doi:10.11120/msor.2001.01010023 · Cited by 2,529
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Self-citationADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Virtual Computational Chemistry Laboratory – Design and Description
Tetko, I. V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V. A., Radchenko, E. V., Zefirov, N. S., Makarenko, A. S., et al. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-8694-y · Cited by 1,500
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
KNIME: The Konstanz Information Miner
Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Sieb, C., Thiel, K., & Wiswedel, B. (2008) · Studies in Classification, Data Analysis, and Knowledge Organization · doi:10.1007/978-3-540-78246-9_38 · Cited by 1,251
The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo- and Bioinformatics
Steinbeck, C., Han, Y., Kuhn, S., Horlacher, O., Luttmann, E., & Willighagen, E. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci025584y · Cited by 1,108
The Corporate Culture Survival Guide
Schein, E. H. (1999) · Cited by 1,056
y-Randomization and Its Variants in QSPR/QSAR
Rücker, C., Rücker, G., & Meringer, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700157b · Cited by 969
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Computer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Self-citationThe maximal affinity of ligands
Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9997 · Cited by 849
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728
Stepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 698
Morgan, P., Van Der Graaf, P. H., Arrowsmith, J., Feltner, D. E., Drummond, K. S., Wegner, C. D., & Street, S. D. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.020 · Cited by 692
Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. K., Rupp, M., Teetz, W., Brandmaier, S., Abdelaziz, A., Prokopenko, V. V., Tanchuk, V. Y., et al. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9440-2 · Cited by 686
Comparison of Different Approaches to Define the Applicability Domain of QSAR Models
Sahigara, F., Mansouri, K., Ballabio, D., Mauri, A., Consonni, V., & Todeschini, R. (2012) · Molecules · doi:10.3390/molecules17054791 · Cited by 633
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Functional group contributions to drug-receptor interactions
Andrews, P. R., Craik, D. J., & Martin, J. L. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a021 · Cited by 535
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Tetko, I. V., Sushko, I., Pandey, A. K., Zhu, H., Tropsha, A., Papa, E., Öberg, T., Todeschini, R., Fourches, D., & Varnek, A. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800151m · Cited by 416
(2008) · Studies in Classification, Data Analysis, and Knowledge Organization · doi:10.1007/978-3-540-78246-9 · Cited by 363
Molecular obesity, potency and other addictions in drug discovery
Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 363
Reactive compounds and in vitro false positives in HTS
Rishton, G. M. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01083-0 · Cited by 351
Cronin, M. T. D., & Schultz, T. W. (2003) · Journal of Molecular Structure: THEOCHEM · doi:10.1016/s0166-1280(02)00616-4 · Cited by 350
Time-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Self-citationGoing further than Lipinski's rule in drug design
Walters, W. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.648612 · Cited by 306
Matched Molecular Pairs as a Medicinal Chemistry Tool: Miniperspective
Griffen, E., Leach, A. G., Robb, G. R., & Warner, D. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200452d · Cited by 282
Assessing drug-likeness – what are we missing?
Vistoli, G., Pedretti, A., & Testa, B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.007 · Cited by 278
Leach, A. G., Jones, H. D., Cosgrove, D. A., Kenny, P. W., Ruston, L., MacFaul, P., Wood, J. M., Colclough, N., & Law, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0605233 · Cited by 277
Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.52 · Cited by 276 · cited 1×
“Consequently, various scoring models for lead-and drug-likeness have been suggested, which are often derived by machine learning methods 27 .”
MethodCan we estimate the accuracy of ADME–Tox predictions?
Tetko, I. V., Bruneau, P., Mewes, H.-W., Rohrer, D. C., & Poda, G. I. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.013 · Cited by 243
Experiences in fragment-based drug discovery
Murray, C. W., Verdonk, M. L., & Rees, D. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.02.006 · Cited by 238
Springthorpe, B., Bailey, A., Barton, P., Birkinshaw, T. N., Bonnert, R. V., Brown, R. C., Chapman, D., Dixon, J., Guile, S. D., Humphries, R. G., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.057 · Cited by 235
The Signature Molecular Descriptor. 1. Using Extended Valence Sequences in QSAR and QSPR Studies
Faulon, J.-L., Visco, D. P., & Pophale, R. S. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci020345w · Cited by 232
Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
Bergström, C. A. S., Norinder, U., Luthman, K., & Artursson, P. (2002) · Pharmaceutical Research · doi:10.1023/a:1014224900524 · Cited by 196
Are the Chemical Structures in Your QSAR Correct?
Young, D., Martin, T., Venkatapathy, R., & Harten, P. (2008) · QSAR & Combinatorial Science · doi:10.1002/qsar.200810084 · Cited by 196
Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity
Ashby, J. (1985) · Environmental Mutagenesis · doi:10.1002/em.2860070613 · Cited by 185
In silico ADME/Tox: why models fail
Stouch, T. R., Kenyon, J. R., Johnson, S. R., Chen, X.-Q., Doweyko, A., & Li, Y. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1025358319677 · Cited by 176
Multi-Parameter Optimization: Identifying High Quality Compounds with a Balance of Properties
D. Segall, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436430 · Cited by 172
Impact of Lipophilic Efficiency on Compound Quality
Tarcsay, Á., Nyíri, K., & Keserű, G. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201388p · Cited by 164
The influence of the 'organizational factor' on compound quality in drug discovery
Leeson, P. D., & St-Gallay, S. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3552 · Cited by 162
[''R"--project for statistical computing].
Dessau, R. B., & Pipper, C. B. (2008) · PubMed · Cited by 161
Matched Molecular Pair Analysis in drug discovery
Dossetter, A. G., Griffen, E., & Leach, A. G. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.03.003 · Cited by 156
Assessment of the Consistency of Medicinal Chemists in Reviewing Sets of Compounds
Lajiness, M. S., Maggiora, G. M., & Shanmugasundaram, V. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049740z · Cited by 143
The signature molecular descriptor
Churchwell, C. J., Rintoul, M. D., Martin, S., Visco, D. P., Kotu, A., Larson, R. S., Sillerud, L. O., Brown, D. C., & Faulon, J. (2003) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2003.10.002 · Cited by 142
Doweyko, A. M. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9162-7 · Cited by 134
Williams, A. J., Ekins, S., & Tkachenko, V. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.02.013 · Cited by 126
Papadatos, G., Alkarouri, M., Gillet, V. J., Willett, P., Kadirkamanathan, V., Luscombe, C. N., Bravi, G., Richmond, N. J., Pickett, S. D., Hussain, J., et al. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100258p · Cited by 126
Drug discovery in the next decade: innovation needed ASAP
Bennani, Y. L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.004 · Cited by 120
Trade-Off Between Accuracy and Interpretability for PredictiveIn SilicoModeling
Johansson, U., Sönströd, C., Norinder, U., & Boström, H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.23 · Cited by 114
Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets
Bruneau, P. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010363y · Cited by 112
A crowdsourcing evaluation of the NIH chemical probes
Oprea, T. I., Bologa, C., Boyer, S. K., Curpan, R. F., Glen, R. C., Hopkins, A. L., Lipinski, C. A., Marshall, G. R., Martin, Y. C., Halip, L., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0709-441 · Cited by 111
Gleeson, M. P., Bravi, G., Modi, S. P., & Lowe, D. M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.002 · Cited by 111
Components of Successful Lead Generation
Davis, A., Keeling, D., Steele, J., Tomkinson, N. P., & Tinker, A. C. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053828411 · Cited by 110
Self-citationThe Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist
Baur, F., Beattie, D., Beer, D., Bentley, D., Bradley, M. E., Bruce, I., Charlton, S. J., Cuenoud, B. M., Ernst, R., Fairhurst, R. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100068m · Cited by 103
Statistical Analysis of the Effects of Common Chemical Substituents on Ligand Potency
Hajduk, P. J., & Sauer, D. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070838y · Cited by 101
Gavaghan, C. L., Arnby, C. H., Blomberg, N., Strandlund, G., & Boyer, S. K. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9095-6 · Cited by 101
On the interpretation and interpretability of quantitative structure–activity relationship models
Guha, R. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9240-5 · Cited by 99
De novodesign: balancing novelty and confined chemical space
Kutchukian, P. S., & Shakhnovich, E. I. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.497534 · Cited by 93
An automated PLS search for biologically relevant QSAR descriptors
Olah, M., Bologa, C., & Oprea, T. I. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-4060-8 · Cited by 91
Dobo, K. L., Greene, N., Fred, C., Glowienke, S., Harvey, J., Hasselgren, C., Jolly, R. A., Kenyon, M. O., Munzner, J. B., Muster, W., et al. (2012) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2012.01.007 · Cited by 87
Kutchukian, P. S., Vasilyeva, N. Y., Xu, J. C., Lindvall, M., Dillon, M. P., Glick, M., Coley, J. D., & Brooijmans, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048476 · Cited by 82
Inflation of correlation in the pursuit of drug-likeness
Kenny, P. W., & Montanari, C. A. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9631-5 · Cited by 81
Judging the Significance of Multiple Linear Regression Models
Livingstone, D. J., & Salt, D. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049111p · Cited by 78
A General Method for Exploiting QSAR Models in Lead Optimization
Lewis, R. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049228d · Cited by 77
Warner, D. J., Griffen, E., & St-Gallay, S. A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100084s · Cited by 74
Why QSAR Fails: An Empirical Evaluation Using Conventional Computational Approach
Huang, J., & Fan, X. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100423u · Cited by 69
QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists
Austin, R. P., Barton, P., Bonnert, R. V., Brown, R. C., Cage, P. A., Cheshire, D. R., Davis, A. M., Dougall, I. G., Ince, F., Pairaudeau, G., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020886c · Cited by 66
Self-citationInterpretation of Nonlinear QSAR Models Applied to Ames Mutagenicity Data
Carlsson, L., Helgee, E. A., & Boyer, S. K. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9002206 · Cited by 64
Stereo Signature Molecular Descriptor
Carbonell, P., Carlsson, L., & Faulon, J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300584r · Cited by 61
Extraction of tacit knowledge from large ADME data sets via pairwise analysis
Keefer, C. E., Chang, G., & Kauffman, G. W. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.003 · Cited by 61
Automatic QSAR modeling of ADME properties: blood–brain barrier penetration and aqueous solubility
Obrezanova, O., Gola, J. M. R., Champness, E. J., & Segall, M. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9193-8 · Cited by 60
Lewis, M. L., & Cucurull-Sanchez, L. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9242-3 · Cited by 56
Beyond Profiling: Using ADMET Models to Guide Decisions
Segall, M., Champness, E. J., Obrezanova, O., & Leeding, C. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900148 · Cited by 55
Dossetter, A. G. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.077 · Cited by 52
Capter 11 Filtering in Drug Discovery
Lipinski, C. A. (2005) · Annual reports in computational chemistry · doi:10.1016/s1574-1400(05)01011-x · Cited by 49
Keefer, C. E., Kauffman, G. W., & Gupta, R. R. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300554t · Cited by 49
Automated QSAR with a Hierarchy of Global and Local Models
Wood, D., Buttar, D., Cumming, J. G., Davis, A. M., Norinder, U., & Rodgers, S. L. (2011) · Molecular Informatics · doi:10.1002/minf.201100107 · Cited by 42
Self-citationChemical Descriptors Are More Important Than Learning Algorithms for Modelling
Young, S. S., Yuan, F., & Zhu, M. (2012) · Molecular Informatics · doi:10.1002/minf.201200031 · Cited by 40
Predictivity of Simulated ADME AutoQSAR Models over Time
Rodgers, S. L., Davis, A. M., Tomkinson, N. P., & Waterbeemd, H. V. D. (2011) · Molecular Informatics · doi:10.1002/minf.201000160 · Cited by 39
Self-citationA critical assessment of modeling safety-related drug attrition
Muthas, D., Boyer, S. K., & Hasselgren, C. (2013) · MedChemComm · doi:10.1039/c3md00072a · Cited by 39
Segall, M., Champness, E., Leeding, C., Lilien, R., Mettu, R. R., & Stevens, B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2003208 · Cited by 35
Integrated Decision Support for Assessing Chemical Liabilities
Spjuth, O., Eklund, M., Helgee, E. A., Boyer, S. K., & Carlsson, L. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200242c · Cited by 33
Use of 3D QSAR Models for Database Screening: A Feasibility Study
Hillebrecht, A., & Klebe, G. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7002945 · Cited by 31
QSAR/QSPR and Proprietary Data
Jorgensen, W. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0680079 · Cited by 31
Kubinyi, H. (2003) · doi:10.1002/9783527618279.ch44c · Cited by 28
Dossetter, A. G., Douglas, A., & O'Donnell, C. (2012) · MedChemComm · doi:10.1039/c2md20155k · Cited by 28
Leach, A. G., Pilling, E. A., Rabow, A. A., Tomasi, S., Asaad, N., Buurma, N. J., Ballard, A. J., & Narduolo, S. (2012) · MedChemComm · doi:10.1039/c2md20010d · Cited by 25
Prospective Prediction of Antitarget Activity by Matched Molecular Pairs Analysis
Warner, D. J., Bridgland-Taylor, M. H., Sefton, C. E., & Wood, D. (2012) · Molecular Informatics · doi:10.1002/minf.201200020 · Cited by 20
What Works and What Does Not: Lessons From Experience in a Pharmaceutical Company
Martin, Y. C. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200610102 · Cited by 18
SAR mining and its application to the design of TRPA1 antagonists
Mills, J. E. J., Brown, A. D., Ryckmans, T., Miller, D. C., Skerratt, S. E., Barker, C. M., & Bunnage, M. E. (2011) · MedChemComm · doi:10.1039/c1md00213a · Cited by 17
ChemModLab: A Web-Based Cheminformatics Modeling Laboratory
Hughes‐Oliver, J. M., Brooks, A., Welch, W. J., Khaledi, M. G., Hawkins, D. M., Young, S. S., Patil, K., Howell, G., Ng, R. T., & Chu, M. T. (2012) · In Silico Biology · doi:10.3233/ci-2008-0016 · Cited by 16
Krämer, C., Tautermann, C. S., Livingstone, D. J., Salt, D. W., Whitley, D. C., Beck, B., & Clark, T. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800318q · Cited by 13
The Rise of the Intelligent Machines in Drug Hunting?
Griffen, E. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.43 · Cited by 6
Cited by
Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00104 · Cited by 5,716
Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab255 · Cited by 2,857
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Metadata
- Authors
- Cumming, J. G., Davis, A. M., Muresan, S., Haeberlein, M., & Chen, H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-11-29
- Volume
- 12
- Issue
- 12
- Pages
- 948-962
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2020859943
- Cited by
- 311
- References
- 107
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.